Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Semaglutida: o Agonista do Receptor GLP-1 A semaglutida uma medicao aprovada no Brasil pela ANVISA para o tratamento da obesidade e diabetes tipo 2
Full criteria are set out in NICE TA875
Pricing analysis and value assessment Cost represents one factor among many in vendor evaluation, but matters for research budget planning
PMID 11146368
Karavia, Andreas Pittaras, Ourania Andreopoulou, Aikaterini Hatziri, Amalia Makrydimitri, Dimitrios Anagnostopoulos, Patroklos Vareltzis, Kyriakos E
US$ 21.34
US$ 26.83
US$ 20.74
